Health care stocks were retreating Thursday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) 0.2% lower.
The iShares Biotechnology ETF (IBB) rose 0.1%.
In corporate news, Walgreens Boots Alliance (WBA) agreed to pay $2.8 million to settle allegations that it violated federal, Massachusetts and Georgia laws by submitting inflated prices for certain generic medications to the states' Medicaid programs, the US Attorney's Office for the District of Massachusetts said. Walgreens shares rose 0.7%.
23andMe (ME) shares surged 50% after a court authorized the company to start an asset sale process through a Chapter 11 plan or pursuant to Section 363 of the US Bankruptcy Code.
Abbott Laboratories (ABT) shares rose 3% after the company said Thursday it has received CE Mark certification in Europe for its Volt pulsed field ablation system to treat patients with heart rhythm disorders.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。